Sanofi India demerger gets a green light Ruchika Sharma10 May 2023 5:33 PM ISTUpon completion of the proposed demerger, Sanofi will continue to own 60.4 percent stake in both entities and Sanofi India Limited shareholders will...
Sanofi concludes acquisition of Provention Bio Ruchika Sharma28 April 2023 12:30 PM ISTParis: Sanofi has announced the completion of its acquisition of Provention Bio, Inc.. The acquisition adds TZIELD (teplizumab-mzwv), a fully owned,...
Elisabeth Moreno to join Sanofi's Diversity, Equity and Inclusion Board Ruchika Sharma18 April 2023 2:30 PM ISTParis: Sanofi has announced the appointment of Elisabeth Moreno, former French Minister for Gender Equality, Diversity and Equal opportunities, to its...
US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris Ruchika Sharma18 April 2023 11:33 AM ISTSanofi said in the lawsuit that it lost hundreds of millions of dollars in sales in the USD 1 billion-plus U.S. epinephrine auto-injector market due...
AstraZeneca, Sanofi, Sobi simplify contractual agreements for Nirsevimab Ruchika Sharma12 April 2023 3:44 PM ISTBeyfortus (nirsevimab), an investigational long-acting antibody designed to protect all infants against RSV infections from birth through their first...
Sanofi to turn India consumer healthcare business into listed entity via demerger: Report Ruchika Sharma31 March 2023 12:00 PM ISTNew Delhi: French drugmaker Sanofi has started a process to turn its India consumer healthcare business into a listed entity via a demerger, the...
Diabetes drug: Sanofi gets marketing authorization from CDSCO for Soliqua Ruchika Sharma28 March 2023 3:14 PM ISTSoliqua (10-40 and 30-60 prefilled pens) is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting...
Sanofi Dupixent gets European Commission nod for children aged 6 months to 5 years old with severe atopic dermatitis Ruchika Sharma22 March 2023 12:45 PM ISTDupixent is an injection administered under the skin at different injection sites.
Sanofi cuts US list price of Lantus, its most-prescribed insulin by 78 percent Ruchika Sharma17 March 2023 12:15 PM ISTParis: Sanofi has announced that it will cut the list price of Lantus (insulin glargine injection) 100 Units/mL, its most widely prescribed insulin in...
Sanofi to acquire Provention Bio for USD 2.9 billion Ruchika Sharma13 March 2023 3:30 PM ISTParis: Sanofi and Provention Bio, Inc have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per...
Sanofi Dupixent application for treatment of chronic spontaneous urticaria in adults, adolescents accepted for USFDA review Ruchika Sharma7 March 2023 3:30 PM ISTDupixent is a fully human monoclonal antibody that inhibits the signaling of the IL-4 and IL-13 pathways and is not an immunosuppressant.
Sanofi, Regeneron Pharma bag USFDA nod for Kevzara to treat polymyalgia rheumatica Ruchika Sharma2 March 2023 1:15 PM ISTPolymyalgia rheumatica often initially presents with pain and stiffness around the neck, shoulder and hip area and symptoms include fatigue, low-grade...
